UroToday.com (@urotoday) 's Twitter Profile
UroToday.com

@urotoday

Largest global online community of #urological medical professionals & patients. #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology

ID: 21319494

calendar_today19-02-2009 17:36:50

113,113K Tweet

27,27K Followers

6,6K Following

UroToday.com (@urotoday) 's Twitter Profile Photo
UroToday.com
@urotoday

2 months ago

The use of PARP inhibitors in #mCRPC with BRCA1/2 alterations. Joaquin Mateo Vall d’Hebron Institute of Oncology (VHIO) and Alicia Morgans, MD, MPH Dana-Farber discuss the poor prognosis associated with these mutations but highlight the effectiveness of PARP inhibitors like olaparib and rucaparib > bit.ly/3VVDJFt

The use of PARP inhibitors in #mCRPC with BRCA1/2 alterations. <a href="/quimmateo/">Joaquin Mateo</a> <a href="/VHIO/">Vall d’Hebron Institute of Oncology (VHIO)</a> and <a href="/CaPsurvivorship/">Alicia Morgans, MD, MPH</a> <a href="/DanaFarber/">Dana-Farber</a> discuss the poor prognosis associated with these mutations but highlight the effectiveness of PARP inhibitors like olaparib and rucaparib &gt; bit.ly/3VVDJFt